Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. [electronic resource]
Producer: 20010628Description: 1701-3 p. digitalISSN:- 0041-1345
- Acute Disease
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Basiliximab
- Daclizumab
- Drug Therapy, Combination
- Female
- Glucocorticoids -- therapeutic use
- Graft Rejection -- prevention & control
- Humans
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation -- immunology
- Male
- Mycophenolic Acid -- analogs & derivatives
- Pancreas Transplantation -- immunology
- Prednisone -- therapeutic use
- Receptors, Interleukin-2 -- immunology
- Recombinant Fusion Proteins
- Survival Rate
- Tacrolimus -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.